CLOPICON AP 75/75

CLOPICON AP 75/75 Capsules

CLOPICON AP 75/75 is a combination medicine containing Clopidogrel 75 mg and Aspirin 75 mg, both recognized as effective antiplatelet agents. This dual therapy is prescribed for the prevention of blood clots, heart attack, ischemic stroke, and other thrombotic cardiovascular disorders. By inhibiting platelet aggregation, it ensures smooth blood circulation and reduces the chances of clot formation inside blood vessels.

Doctors commonly recommend CLOPICON AP 75/75 for patients with a history of acute coronary syndrome, ischemic heart disease, post-angioplasty, stent placement, or peripheral arterial disease. The combination of Clopidogrel and Aspirin provides a synergistic effect, making it more effective in reducing cardiovascular risks compared to single-drug therapy.

This capsule should be taken exactly as prescribed by the physician, usually once daily with or without food. Patients should not discontinue the medicine suddenly, as it may increase the risk of clotting and related complications.

Some individuals may experience side effects like gastritis, stomach irritation, minor bleeding, or bruising. Regular medical supervision and follow-up are important for long-term safety. When taken correctly, CLOPICON AP 75/75 plays a vital role in protecting heart health and preventing life-threatening clot-related conditions.